STOCKNO.DE
Institutional ownership intelligence
Research
Schedule 13G/A

VIR Schedule 13G/A filing by State Street

State Street reported beneficial ownership of 5.6M shares, representing 4.1% of Vir Biotechnology, Inc. in this filing.

FiledOct 18, 2024
Ownership dateSep 30, 2024
Reported shares5.6M
Reported ownership4.1%
Ownership details

Voting and dispositive power reported in the filing

These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.

Sole voting power 0
Shared voting power 5.4M
Sole dispositive power 0
Shared dispositive power 5.6M
Price context

Price dates alongside the ownership filing

Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.

Close near filing date$7.63as of Oct 18, 2024
Latest tracked price$9.11as of Aug 5, 2026
Source

Original filing and accession

Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.

Reporting filer
State Street
CIK
CIK0000093751
Accession
0000093751-24-000892
Form
Schedule 13G/A
Open SEC filing View VIR ownership history
Read the filing in context

Understand what a Schedule 13 filing does—and does not—tell you.

How to read a Schedule 13G → Does a 13G mean the shares were just bought? → Filing date vs. ownership date →